ArticleNeurology2020
Relationship between early follow-up and readmission within 30 and 90 days after ischemic stroke.
Article in Neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 4 syntheses or guidelines pooled it.
- Outpatient Follow-Up and 30-Day Readmissions: A Systematic Review and Meta-Analysis.JAMA network open · 2025Pooled it
- Factors associated with post-stroke readmission: a systematic review and meta analysis.Scientific reports · 2025Pooled it
- Associations Between Early Physician Follow-up and Post-discharge Outcomes: A Systematic Review and Meta-analysis.Journal of general internal medicine · 2025Pooled it
- Outpatient Follow-Up Visits to Reduce 30-Day All-Cause Readmissions for Heart Failure, COPD, Myocardial Infarction, and Stroke: A Systematic Review and Meta-Analysis.Preventing chronic disease · 2024Pooled it
- Development and internal validation of a 30-day readmission risk model for older adults using Swiss electronic health record data: a retrospective cohort study.BMC geriatrics · 2026Article
- Treatment Patterns of Antiseizure Medication for Poststroke Prophylaxis Among Older Adults.Journal of the American Heart Association · 2026Article
- HARMONICS: feasibility of a holistic value-based care hybrid programme that maximises clinical outcomes after stroke.European stroke journal · 2026Article
- Impact of white matter hyperintensities on cognitive, motor and functional recovery in veterans following acute/subacute stroke: a prospective study.BMJ neurology open · 2026Article
- Article
- Association of Outpatient Follow-Up With 30-Day Readmission After Epilepsy or Seizure Discharge in Medicare Beneficiaries Aged 65 and Older.Neurology · 2025Article
- Predictors of unplanned hospital readmissions and emergency department revisits in patients with acute ischemic stroke.Frontiers in neurology · 2025Article
- Heart rate variability in chronic ischemic stroke: analysis during the sleep-wake cycle.Arquivos de neuro-psiquiatria · 2024Article
- Predictors of follow-up care for critically-ill patients with seizures and epileptiform abnormalities on EEG monitoring.Clinical neurology and neurosurgery · 2024Article
- A novel risk score predicting 30-day hospital re-admission of patients with acute stroke by machine learning model.European journal of neurology · 2024Observational
- Predictors of not maintaining regular medical follow-up after stroke.BMC neurology · 2023Article
- High Risk Features Contributing to 30-Day Readmission After Acute Ischemic Stroke: A Single Center Retrospective Case-Control Study.The Neurohospitalist · 2022Article
- Evaluating Outcome Prediction Models in Endovascular Stroke Treatment Using Baseline, Treatment, and Posttreatment Variables.Stroke (Hoboken, N.J.) · 2021Article
- Role of caregiver factors in outpatient medical follow-up post-stroke: observational study in Singapore.BMC family practice · 2021Observational
- From Three-Months to Five-Years: Sustaining Long-Term Benefits of Endovascular Therapy for Ischemic Stroke.Frontiers in neurology · 2021Review
- Admission and Readmission/Death Patterns in Hospitalized and Non-hospitalized First-Ever-in-a-Lifetime Stroke Patients During the First Year: A Population-Based Incidence Study.Frontiers in neurology · 2021Article
Corrections and comments
- Commented on by
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo examine whether early follow-up with primary care or neurology is associated with lower all-cause readmissions within 30 and 90 days after acute ischemic stroke admission.
methodsWe performed a retrospective cohort study of patients who were discharged home after acute ischemic stroke, identified by ICD-9 and ICD-10 codes, using PharMetrics, a nationally representative claims database of insured Americans from 2009 to 2015. The primary predictor was outpatient primary care or neurology follow-up within 30 and 90 days of discharge, and the primary outcome was all-cause 30- and 90-day readmissions. Multivariable Cox models were used with primary care and neurology visits specified as time-dependent covariates, with adjustment for patient demographics, comorbid conditions, and stroke severity measures.
resultsThe cohort included 14,630 patients. Readmissions within 30 days occurred in 7.3% of patients, and readmissions within 90 days occurred in 13.7% of patients. By 30 days, 59.3% had a primary care visit, and 24.4% had a neurology visit. Primary care follow-up was associated with reduced 30-day readmissions (hazard ratio [HR] 0.84, 95% confidence interval [CI] 0.72-0.98). Primary care follow-up before 90 days did not reach significance (HR 0.92, 95% CI 0.83-1.03). Neurology follow-up was not associated with reduced readmissions within 30 or 90 days (HR 1.05, 95% CI; HR 1.00, 95% CI, respectively).
conclusionEarly outpatient follow-up with primary care is associated with a reduction in 30-day hospital readmissions. Early outpatient follow-up may represent an important opportunity for intervention after acute stroke admissions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.